LGMar 22, 2025Code
ConSol: Sequential Probability Ratio Testing to Find Consistent LLM Reasoning Paths EfficientlyJaeyeon Lee, Guantong Qi, Matthew Brady Neeley et al.
Recent advancements in large language models (LLMs) integrating explicit reasoning, such as OpenAI's o3-mini, DeepSeek-R1, and QWQ-32B, enable smaller models to solve complex tasks by generating intermediate reasoning steps prior to providing answers. However, this approach significantly increases computational costs, both monetarily and environmentally. The widely-used self-consistency method further exacerbates these costs by aggregating multiple reasoning paths to improve accuracy, often requiring between 40 to 64 samples per task. Although aggregation effectively reduces variance and bias, additional sampling can lead to diminishing returns when early samples yield consistent results. To address inefficiencies, we propose leveraging Sequential Probability Ratio Testing (SPRT) to dynamically terminate sampling once sufficient consistency is achieved. We calibrate SPRT parameters specifically for LLM applications, accounting for sensitivity to detect the mode of the distribution. Our experiments demonstrate that incorporating SPRT significantly enhances token efficiency, achieving comparable accuracy to self-consistency methods but at a substantially reduced computational cost. To promote transparency and facilitate reproducibility, we have made the source code and datasets used in our experiments publicly available at our GitHub repository: https://github.com/LiuzLab/consol, or available as a PyPI package: pip install consol. We hope that this resource will support further research and encourage the development of new methods building upon our work.
GNNov 4, 2025
LA-MARRVEL: A Knowledge-Grounded and Language-Aware LLM Reranker for AI-MARRVEL in Rare Disease DiagnosisJaeyeon Lee, Hyun-Hwan Jeong, Zhandong Liu
Diagnosing rare diseases requires linking gene findings with often unstructured reference text. Current pipelines collect many candidate genes, but clinicians still spend a lot of time filtering false positives and combining evidence from papers and databases. A key challenge is language: phenotype descriptions and inheritance patterns are written in prose, not fully captured by tables. Large language models (LLMs) can read such text, but clinical use needs grounding in citable knowledge and stable, repeatable behavior. We explore a knowledge-grounded and language-aware reranking layer on top of a high-recall first-stage pipeline. The goal is to improve precision and explainability, not to replace standard bioinformatics steps. We use expert-built context and a consensus method to reduce LLM variability, producing shorter, better-justified gene lists for expert review. LA-MARRVEL achieves the highest accuracy, outperforming other methods -- including traditional bioinformatics diagnostic tools (AI-MARRVEL, Exomiser, LIRICAL) and naive large language models (e.g., Anthropic Claude) -- with an average Recall@5 of 94.10%, a +3.65 percentage-point improvement over AI-MARRVEL. The LLM-generated reasoning provides clear prose on phenotype matching and inheritance patterns, making clinical review faster and easier. LA-MARRVEL has three parts: expert-engineered context that enriches phenotype and disease information; a ranked voting algorithm that combines multiple LLM runs to choose a consensus ranked gene list; and the AI-MARRVEL pipeline that provides first-stage ranks and gene annotations, already known as a state-of-the-art method in Rare Disease Diagnosis on BG, DDD, and UDN cohorts. The online AI-MARRVEL includes LA-MARRVEL as an LLM feature at https://ai.marrvel.org . We evaluate LA-MARRVEL on three datasets from independent cohorts of real-world diagnosed patients.